SecBot SecBot
8-K ·Filed Jun 22, 2026

ANAB

ANAPTYSBIO, INC
NEUTRAL
Impact 2/10
Horizonweeks Processed4mo ago SEC0001193125-26-277505
8-K Item 1.01 + 5.02 (likely routine officer/director compensation agreement)
Actionable Insight • Neutral

This sublease is a routine real estate cost-sharing arrangement with no material financial impact. Monitor the upcoming 10-K/T for any rent amounts or impairment implications, but no immediate trading catalyst.

DirectionNeutral
Confidencehigh
Horizonweeks

How the stock moved after the report

NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60
Entry
$59.43
T+0 close · Jun 22, 2026 · via day close
Latest settled
−8.62%
T+60 · $54.31
Vs SPY
−11.86%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Jun 23 $59.43entry
  2. T+1 · 5mo ago −1.60%α −1.55% · $58.48
  3. T+5 · 5mo ago +11.00%α +9.99% · $65.97
  4. T+20 · 4mo ago −15.38%α −16.54% · $50.29
  5. T+60 · 2mo ago −8.62%α −11.86% · $54.31
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

AnaptysBio entered into a sublease agreement with First Tracks Biotherapeutics for approximately 45,057 rentable square feet of its San Diego headquarters. The 12-month sublease transfers occupancy costs to First Tracks while AnaptysBio remains primarily liable under the master lease. This is a routine real estate transaction with no material financial impact disclosed.

Key Facts

  • Sublease of ~45,057 rentable square feet at 10770 Wateridge Circle, San Diego to First Tracks Biotherapeutics
  • 12-month initial term starting June 15, 2026, with extension options through April 2028
  • First Tracks pays monthly Basic Rent plus Additional Rent under the Master Lease; AnaptysBio remains primarily liable to the master landlord
  • First Tracks can terminate at any time with 3 months' notice
  • No financial terms (dollar amounts, rent) were disclosed in the filing

Financial Impact

No financial figures disclosed; sublease transfers occupancy costs but AnaptysBio retains primary lease liability

Risk Factors

  • AnaptysBio remains liable under the master lease if First Tracks defaults or terminates early
  • No disclosed financial terms limit visibility into cost savings or income from the sublease

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
94% bullish (17 analysts)

Investment Themes

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001193125-26-277505
Document: 0001193125-26-277505-index-headers.html0001193125-26-277505
Document: 0001193125-26-277505-index.html0001193125-26-277505
Document: 0001193125-26-277505.txt0001193125-26-277505

Track record

28 reports on ANAB

Performance horizon

10 of 19 bullish or bearish reports moved the stock their way by T+1. Best: +41.26% at T+60 after the Mar 3, 2026 report. 13 of 19 went positive at some point.

Filters
  1. Nov 16, 2026today SC 13G/A Neutral 2/10 Entry $46.25 Now $45.73 −1.12% settles Nov 17
  2. Nov 12, 20264d ago Press Release Bearish 4/10 Entry $46.25 to $45.73 Now $45.73 +1.12% ▲ +1.12% −0.79% vs SPY
  3. Nov 6, 202610d ago Institutional Cluster Neutral 2/10 Entry $46.45 to $47.97 Now $45.73 −1.55% ▲ +3.27% +0.91% vs SPY
  4. Sep 21, 20268w ago Press Release Neutral 5/10 Entry $53.92 to $50.77 Now $45.73 −15.19% ▼ −5.84% −5.12% vs SPY
  5. Aug 12, 202613w ago Institutional Cluster Bullish 5/10 Entry $56.02 to $58.47 Now $45.73 −18.37% ▲ +4.37% +4.57% vs SPY
  6. Jun 29, 202620w ago 144 Bearish 6/10 Entry $67.50 to $65.43 Now $45.73 +32.25% ▲ +3.07% +2.93% vs SPY
  7. Jun 29, 202620w ago DEFA14A Neutral 2/10 Entry $67.50 to $65.43 Now $45.73 −32.25% ▼ −3.07% −2.93% vs SPY
  8. Jun 26, 202620w ago 144 Bearish 6/10 Entry $65.97 to $67.50 Now $45.73 +30.68% ▼ −2.32% −1.54% vs SPY
  9. Jun 22, 202621w ago 8-K Neutral 2/10 Viewing Entry $59.43 to $58.48 Now $45.73 −23.05% ▼ −1.60% −1.55% vs SPY
  10. Jun 17, 202621w ago 144 Bearish 5/10 Entry $57.51 to $59.99 Now $45.73 +20.48% ▼ −4.31% −4.63% vs SPY
Showing 10 of 28

US Market Status

Market Closed · Opens in 6h 34m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jun 22, 2026